Condition: Coronary Artery Disease · Sponsor: Vastra Gotaland Region
The STICH-SWEDEHEART trial will compare PCI vs CABG for revascularization of patients with HF and LV systolic dysfunction (LV ejection fraction (LVEF) \<40%) and multi-vessel coronary artery disease.
This description comes directly from the study's public registry record.
Björn Redfors, MD, PhD · +46313427543 · Bjoern.Redfors@wlab.gu.se
Elmir Omerovic, MD, PhD · +46 31 3421000 · elmir@wlab.gu.se
Always discuss trial participation with your own doctor first.
| Kardiologen | Gothenburg, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05329285